(e,e,e,e)-squalene

(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (e,e,e,e)-squalene?

(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene

MeSH term MeSH ID Detail
Fatigue D005221 10 associated lipids
Photosensitivity Disorders D010787 8 associated lipids
Chondrodysplasia Punctata D002806 8 associated lipids
Fibrosarcoma D005354 8 associated lipids
Chronic Disease D002908 7 associated lipids
Alopecia Areata D000506 6 associated lipids
Parasitemia D018512 5 associated lipids
Tinea Versicolor D014010 5 associated lipids
Keratitis, Herpetic D016849 5 associated lipids
Leukemia, Hairy Cell D007943 5 associated lipids
Per page 10 20 50 100 | Total 84

PubChem Associated disorders and diseases

What pathways are associated with (e,e,e,e)-squalene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (e,e,e,e)-squalene?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (e,e,e,e)-squalene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (e,e,e,e)-squalene

Download all related citations
Per page 10 20 50 100 | Total 1766
Authors Title Published Journal PubMed Link
Baudner BC et al. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). 2009 Pharm. Res. pmid:19255727
Fox CB et al. Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. 2011 Pharm Dev Technol pmid:20550484
Ott G et al. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. 1995 Pharm Biotechnol pmid:7551221
Adrangui M et al. [Water-surfactant-oil diagrams based on perhydrosqualene and triglycerides (Miglyol 812). Study of emulsion phases and stability]. 1979 Pharm Acta Helv pmid:515109
Vesikari T et al. Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. 2010 Pediatrics pmid:20819892
Esposito S et al. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. 2011 Pediatrics pmid:21464195
Ketomäki A et al. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia. 2003 Pediatr. Res. pmid:12612218
Vesikari T et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. 2009 Pediatr. Infect. Dis. J. pmid:19561422
Huber VC and McCullers JA Vaccines against pandemic influenza: what can be done before the next pandemic? 2008 Pediatr. Infect. Dis. J. pmid:18820570
Langley JM et al. Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. 2012 Pediatr. Infect. Dis. J. pmid:22801094
Block SL et al. Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. 2012 Pediatr. Infect. Dis. J. pmid:22481427
Mitchell DK et al. Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers. 2002 Pediatr. Infect. Dis. J. pmid:11840080
Nassim C et al. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. 2012 Pediatr. Infect. Dis. J. pmid:22418661
Gavaldà J et al. Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. 2013 Pediatr Transplant pmid:23692602
Lee KH et al. Squalene aspiration pneumonia in children: radiographic and CT findings as the first clue to diagnosis. 2005 Pediatr Radiol pmid:15806404
Kim ES et al. Squalene-induced exogenous lipoid pneumonia in an infant. 2009 Pediatr Int pmid:19799746
Saint-Léger D [Normal and pathologic sebaceous function. Research in a shallow milieu?]. 2003 Pathol. Biol. pmid:14567194
Bouissou H et al. [Cutaneous cholesterol and phospholipids in atherosclerosis]. 1976 Paroi Arterielle pmid:1012738
Elnaiem DA et al. Chemical factors controlling oviposition of Lutzomyia longipalpis (Diptera: Psychodidae). 1991 Parassitologia pmid:1841210
Burkhart CN et al. Cerumen composition by flash pyrolysis-gas chromatography/mass spectrometry. 2001 Otol. Neurotol. pmid:11698786
Hess BA Formation of the C ring in the lanosterol biosynthesis from squalene. 2003 Org. Lett. pmid:12529131
Tanaka H et al. Enzymatic formation of indole-containing unnatural cyclic polyprenoids by bacterial squalene:hopene cyclase. 2005 Org. Lett. pmid:16354088
Tanaka H et al. 1-methylidenesqualene and 25-methylidenesqualene as active-site probes for bacterial squalene:hopene cyclase. 2004 Org. Lett. pmid:14986979
Hoshino T et al. β-Amyrin biosynthesis: the critical role of steric volume at C-19 of 2,3-oxidosqualene for its correct folding to generate the pentacyclic scaffold. 2014 Org. Lett. pmid:24960408
Morimoto Y et al. Biomimetic epoxide-opening cascades of oxasqualenoids triggered by hydrolysis of the terminal epoxide. 2013 Org. Lett. pmid:23721415
Lodeiro S et al. A putative precursor of isomalabaricane triterpenoids from lanosterol synthase mutants. 2006 Org. Lett. pmid:16435854
Winne JM et al. Application of the B-alkyl suzuki-miyaura cross-coupling reaction to the stereoselective synthesis of analogues of (3S)-oxidosqualene. 2006 Org. Lett. pmid:17020310
Segura MJ et al. Arabidopsis thaliana LUP1 converts oxidosqualene to multiple triterpene alcohols and a triterpene diol. 2000 Org. Lett. pmid:10930257
Xiong Z et al. A short total synthesis of (+)-omaezakianol via an epoxide-initiated cationic cascade reaction. 2010 Org. Lett. pmid:20218639
Yang P et al. Two concise enantioselective total syntheses of (-)-glabrescol implicate alternative biosynthetic pathways starting from squalene. 2012 Org. Lett. pmid:22817611
Hess BA and Smentek L Concerted nature of AB ring formation in the enzymatic cyclization of squalene to hopenes. 2004 Org. Lett. pmid:15151397
Hoshino T and Ohashi S Importance of the methyl group at C10 of squalene for hopene biosynthesis and novel carbocyclic skeletons with 6/5 + 5/5 + (6) ring system(s). 2002 Org. Lett. pmid:12123374
Liu YT et al. Protein engineering of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase into parkeol synthase. 2012 Org. Lett. pmid:23043506
Abe T and Hoshino T Enzymatic cyclizations of squalene analogs with threo- and erythro-diols at the 6,7- or 10,11-positions by recombinant squalene cyclase. Trapping of carbocation intermediates and mechanistic insights into the product and substrate specificities. 2005 Org. Biomol. Chem. pmid:16106294
Cheng J and Hoshino T Cyclization cascade of the C33-bisnorheptaprenoid catalyzed by recombinant squalene cyclase. 2009 Org. Biomol. Chem. pmid:19343258
Matsuda SP et al. Mechanistic insights into triterpene synthesis from quantum mechanical calculations. Detection of systematic errors in B3LYP cyclization energies. 2006 Org. Biomol. Chem. pmid:16446812
Morimoto Y et al. Two-directional synthesis and stereochemical assignment toward a C2 symmetric oxasqualenoid (+)-intricatetraol. 2006 Org. Biomol. Chem. pmid:17036107
Winne JM et al. Nonenzymic polycyclization of analogues of oxidosqualene with a preformed C-ring. 2008 Org. Biomol. Chem. pmid:18480904
Nakano S et al. Squalene-hopene cyclase: insight into the role of the methyl group on the squalene backbone upon the polycyclization cascade. Enzymatic cyclization products of squalene analogs lacking a 26-methyl group and possessing a methyl group at C7 or C11. 2004 Org. Biomol. Chem. pmid:15254628
Hoshino T et al. Squalene-hopene cyclase: final deprotonation reaction, conformational analysis for the cyclization of (3R,S)-2,3-oxidosqualene and further evidence for the requirement of an isopropylidene moiety both for initiation of the polycyclization cascade and for the formation of the 5-membered E-ring. 2004 Org. Biomol. Chem. pmid:15136801
Morimoto Y The role of chemical synthesis in structure elucidation of oxasqualenoids. 2008 Org. Biomol. Chem. pmid:18452003
Hoshino T et al. Production of epoxydammaranes by the enzymatic reactions of (3R)- and (3S)-2,3-squalene diols and those of 2,3:22,23-dioxidosqualenes with recombinant squalene cyclase and the mechanistic insight into the polycyclization reactions. 2007 Org. Biomol. Chem. pmid:17315066
O'Neill HJ and Gershbein LL Lipids of human and equine smegma. 1976 Oncology pmid:1018879
Peltola P et al. Visceral obesity is associated with high levels of serum squalene. 2006 Obesity (Silver Spring) pmid:16899796
Ostlund RE et al. Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. 2002 Nutr. Rev. pmid:12462517
Cabrera-Vique C et al. Bioactive compounds and nutritional significance of virgin argan oil--an edible oil with potential as a functional food. 2012 Nutr. Rev. pmid:22537213
SQUALENE, a precursor of cholesterol. 1954 Nutr. Rev. pmid:13166142
Madani KA Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. 2003 Nutr. Rev. pmid:12795450
SQUALENE and cholesterol synthesis in the human skin. 1956 Nutr. Rev. pmid:13309889
Nissinen MJ et al. Effects of plant stanol esters supplied in a fat free milieu by pastilles on cholesterol metabolism in colectomized human subjects. 2006 Nutr Metab Cardiovasc Dis pmid:16935701
Scolastici C et al. Squalene does not exhibit a chemopreventive activity and increases plasma cholesterol in a Wistar rat hepatocarcinogenesis model. 2004 Nutr Cancer pmid:15572303
MELCHIORRI-SANTOLINI U and RENZINI G [Detection of sterols and squalene in sporigenic bacteria]. 1960 Nov-Dec Nuovi Ann Ig Microbiol pmid:13769177
RENZINI G [Detection of sterols and squalene in B. coli aerogenes]. 1960 Nov-Dec Nuovi Ann Ig Microbiol pmid:13740904
Allain V et al. Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices. 2012 Nucleic Acids Res. pmid:22075995
Imaeda K et al. [Effect of sex-hormone on composition of rat skin surface lipid]. 1987 Nippon Yakurigaku Zasshi pmid:3428773
Shimizu Y et al. [Innovation of vaccine adjuvants]. 2008 Nippon Rinsho pmid:18939490
Uotani J [The changes of sterol in lenses]. 1984 Nippon Ganka Gakkai Zasshi pmid:6711397
Nishimura S [Fasting serum squalene in patients with gallstones and hyperlipidemia]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3385962
Yoshino K and Matsuo I [Squalene peroxide formation by UVA irradiation with or without 8-MOP (author's transl)]. 1981 Nihon Hifuka Gakkai Zasshi pmid:6971356
Torinuki W et al. [Emission spectral analysis of ultraweak chemiluminescence from linolenic acid and squalene peroxides (author's transl)]. 1982 Nihon Hifuka Gakkai Zasshi pmid:6978954
Inomata N [Symposium I: aging and the activity of the sebaceous glands]. 1973 Nihon Hifuka Gakkai Zasshi pmid:4546667
Xue Z et al. Divergent evolution of oxidosqualene cyclases in plants. 2012 New Phytol. pmid:22150097
Inagaki YS et al. Investigation of the potential for triterpene synthesis in rice through genome mining and metabolic engineering. 2011 New Phytol. pmid:21501172
Petrik MS et al. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. 2007 Neuromolecular Med. pmid:17114826
Paoletti P et al. Lipid biosynthesis from labelled precursors in an experimental brain tumor-bearing mouse. 1966 Neurochirurgia (Stuttg) pmid:5966653
Johnson RC and Shah SN Metabolism of intracerebrally injected mevalonate in brain of suckling and young adult rats. 1985 Neurochem. Res. pmid:3925358
Esposito S et al. An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. 2011 Nephrol. Dial. Transplant. pmid:20974645
Das B et al. Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. 2008 Neoplasia pmid:18813359
Autrum H et al. [Squalene in the glandular secretion of mammals]. 1968 Naturwissenschaften pmid:5726004
Wadman M Race is on for flu vaccine. 2005 Nature pmid:16267526
Thoma R et al. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. 2004 Nature pmid:15525992
Clark RP and Shirley SG Identification of skin in airborne particulate matter. 1973 Nature pmid:4585846
LUCY JA and DINGLE JT FAT-SOLUBLE VITAMINS AND BIOLOGICAL MEMBRANES. 1964 Nature pmid:14222261
WOOTTON JM and WRIGHT LD Biosynthesis of squalene by the annelid Lumbricus terrestris. 1960 Nature pmid:13786660
ALAM SQ et al. Detection and estimation of squalene in leaves. 1962 Nature pmid:13860005
Bird CW et al. Steroids and squalene in Methylococcus capsulatus grown on methane. 1971 Nature pmid:4929985
GOSSELIN L et al. Particulate enzyme system for the synthesis of squalene from 2-(14C)-mevalonic acid. 1962 Nature pmid:13900654
Phytochemistry: terpenoids for progress. 1970 Nature pmid:5437511
Lewis RW Distribution of dietary squalene in a wandering Albatross, diomedea exultans. 1969 Nature pmid:5358352
Boyd GS and Onajobi FD Control of cholesterol biosynthesis by a plasma apo-lipoprotein. 1969 Nature pmid:5789314
Brassell SC et al. Specific acyclic isoprenoids as biological markers of methanogenic bacteria in marine sediments. 1981 Nature pmid:7219553
HELLER JH et al. Squalene content of various shark livers. 1957 Nature pmid:13430738
Ackman RG et al. Unusual occurrence of squalene in a fish, the eulachon Thaleichthys pacificus. 1968 Nature pmid:5701840
Naughton C et al. Transcription forms and remodels supercoiling domains unfolding large-scale chromatin structures. 2013 Nat. Struct. Mol. Biol. pmid:23416946
Ali NA et al. Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. 2010 Nat. Prod. Res. pmid:21104527
Harrison DM The biosynthesis of triterpenoids and steroids. 1985 Nat Prod Rep pmid:3913885
Abe I et al. Inhibitors of squalene biosynthesis and metabolism. 1994 Nat Prod Rep pmid:15200015
Connolly JD and Hill RA Triterpenoids. 2002 Nat Prod Rep pmid:12195814
Zhang XH et al. Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods. 2012 Nat Prod Commun pmid:22428257
Pili B et al. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. 2010 Nanoscale pmid:20820745
Réjiba S et al. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. 2011 Nanomedicine pmid:21419876
Couvreur P et al. Squalenoyl nanomedicines as potential therapeutics. 2006 Nano Lett. pmid:17090088
Finotti E et al. Synergistic effects of alpha-tocopherol, beta-sitosterol and squalene on antioxidant activity assayed by crocin bleaching method. 2000 Nahrung pmid:11075383
Stephenson I et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. 2008 N. Engl. J. Med. pmid:18843132
Pass RF et al. Vaccine prevention of maternal cytomegalovirus infection. 2009 N. Engl. J. Med. pmid:19297572
Clark TW et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. 2009 N. Engl. J. Med. pmid:19745215
Vesikari T et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. 2011 N. Engl. J. Med. pmid:21995388
Sancho A et al. More on influenza vaccine in young children. 2012 N. Engl. J. Med. pmid:22738111
Miettinen TA et al. Serum squalene and methyl sterols. 1970 N. Engl. J. Med. pmid:5470273
Villee CA Shark oil and medicine. 1970 N. Engl. J. Med. pmid:5462581